Profiles

Veronika Josefa Wirtz, PhD, MSc

Professor, Global Health - Boston University School of Public Health

vwirtz@bu.edu

Biography

Veronika J. Wirtz, MSc, PhD is a Professor in the Department of Global Health at the Boston University School of Public Health, where she is also Director of the World Health Organization Collaborating Center in Pharmaceutical Policy. Her research focuses on health system strengthening and policy and program evaluations of medicines access and utilization. She is a Visiting Professor of the National Institute of Public Health (INSP) in Mexico.

Her interest and expertise include medicines price analysis, generic medicines policies, quality use of medicines, access to medicines for non-communicable diseases and the role of the private sector to promote equitable access and efficient use of medicines in low and middle income countries. Among other international studies Dr Wirtz carried out cross-national comparison of medicines consumption using large sales data bases to inform policy making about adequate use of medicines and prevention of antimicrobial resistance.

Between 2014 and 2016 she was the Co-Chair of The Lancet Commission on Essential Medicine Policies. The Commission had the goals of (1) re-confirming the ongoing relevance, and the crucial need of comprehensive essential medicines policies to achieve broader global health and sustainable development goals, especially universal health coverage and (2) formulating recommendations for global essential medicine policies for the next two decades. The Report of the Commission Essential Medicines for Universal Coverage was published in 2016.

From 2004 to 2012 she was researcher and lecturer at the National Institute of Public Health (INSP) in Mexico and a founding member and Head of the Medicines in Public Health Research Group which is a multi-disciplinary team of 15 experts in health economics, epidemiology, social science carrying out pharmaceutical policy analysis in Mexico and Latin America. Over the last years she has regularly taught short courses in Pharmacoepidemiology and Medicines Utilization Research at INSP in Mexico.

She has worked as a technical adviser for various international organizations, among them the World Health Organization, the Pan American Health Organization, the World Bank, the Global Fund to fight AIDS, Tuberculosis and Malaria, the Bill and Melinda Gates Foundation, Alliance for Health Systems and Policy Research, Health Action International and the Ford Foundation. She has also worked with the Ministry of Health in Mexico on various program evaluations and capacity building initiatives. She published widely in international peer review journals such as The Lancet, British Medical Journal, World Health Organization Bulletin, Health Policy and Planning, Health Policy, Value in Health, Social Science and Medicine, Tropical Medicine and International Health. Since Fall 2016 she is Associate Editor of Health Systems & Reform, a leading journal publishing health system and policy research.

She received her training as a pharmacist from Albert-Ludwigs-University in Freiburg, Germany and her Master in Clinical Pharmacy and PhD from the University of London in the UK.

Education

  • University of London, PhD Field of Study: Pharmaceutical Policy
  • University of London, MSc Field of Study: Pharmacy
  • Albert-Ludwigs-Universität Freiburg, BS Field of Study: Pharmacy

Classes Taught

  • SPHGH722
  • SPHGH760
  • SPHGH888
  • SPHGH941

Publications

  • Published on 7/10/2025

    Ching C, Zaman MH, Wirtz VJ. Policy discourse on AMR in food-producing animals: examining framing and language for effective communication. JAC Antimicrob Resist. 2025 Aug; 7(4):dlaf113. PMID: 40642516.

    Read At: PubMed
  • Published on 5/21/2025

    Wirtz VJ, Hogerzeil HV, Gray AL. Accelerating progress on essential medicines: a new Lancet Commission. Lancet. 2025 May 21. PMID: 40412429.

    Read At: PubMed
  • Published on 4/3/2025

    Caetano MC, Emmerick ICM, Campos MR, Pires DC, Wirtz VJ, Luiza VL. Effect of Covid-19 pandemic on azithromycin, chloroquine/hydroxychloroquine and ivermectin outpatient consumption in Brazil: a joinpoint regression analysis. BMC Public Health. 2025 Apr 03; 25(1):1250. PMID: 40181299.

    Read At: PubMed
  • Published on 3/29/2025

    Goto A, Wirtz VJ, Hayashi M, Hasegawa J, Fukushima K, Matsuda H, Nakai A. Access to medical abortion and abortion care in Japan. Prev Med Rep. 2025 May; 53:103041. PMID: 40264747.

    Read At: PubMed
  • Published on 3/17/2025

    Costa E, Del Grosso V, Cappello B, Genazzani AA, Huttner B, Leufkens HGM, Magrini N, Nonino F, Wirtz VJ, van den Ham HA, Moja L. Medicines not recommended for inclusion in the who essential medicines list: a retrospective observational study. Front Med (Lausanne). 2025; 12:1517020. PMID: 40166059.

    Read At: PubMed
  • Published on 3/8/2025

    Kaur P, Chaisson LH, Kiragu ZW, Buddadhumaruk P, Austin AF, Gao Y, Wirtz VJ, Arbeit RD, Fetalvero KB, Nguyen HB, Nguyen NV, Ha H, Eisenach K, Walter ND, Mitnick CD, Gler MTS, Phan H, Nahid P, Phillips PPJ, Horsburgh CR, Velásquez GE. Study protocol for a duration-randomized clinical trial to determine the optimal length of treatment for multidrug-resistant tuberculosis with a 5-drug regimen: The DRAMATIC trial. Contemp Clin Trials. 2025 May; 152:107875. PMID: 40064371.

    Read At: PubMed
  • Published on 12/27/2024

    Campos-Rivera PA, Alfaro-Ponce B, Ramírez-Pérez M, Bernal-Serrano D, Contreras-Loya D, Wirtz VJ. Quality of information and social norms in Spanish-speaking TikTok videos as levers of commercial practices: The case of semaglutide. Soc Sci Med. 2025 Feb; 366:117646. PMID: 39827687.

    Read At: PubMed
  • Published on 12/24/2024

    Vogler S, Zimmermann N, Knoll V, Salcher-Konrad M, Windisch F, Espin J, Mantel-Teeuwisse AK, Panteli D, Suleman F, Wirtz VJ, Babar ZU. 'We need to be part of the solution': lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies. J Pharm Policy Pract. 2024; 17(Suppl 1):2442002. PMID: 39763616.

    Read At: PubMed
  • Published on 10/15/2024

    Aljadeeah S, Payedimarri AB, Kielmann K, Michielsen J, Wirtz VJ, Ravinetto R. Access to medicines among asylum seekers, refugees and undocumented migrants across the migratory cycle in Europe: a scoping review. BMJ Glob Health. 2024 Oct 15; 9(10). PMID: 39414330.

    Read At: PubMed
  • Published on 8/1/2024

    Jenei K, Wirtz VJ. Measuring access to essential medicines in the sustainable development goals. Bull World Health Organ. 2024 Aug 01; 102(8):555-555A. PMID: 39091967.

    Read At: PubMed

News & In the Media